Pharsight

BOEHRINGER INGELHEIM ANIMAL HEALTH USA patents facing oppositions

Top patents of BOEHRINGER INGELHEIM ANIMAL HEALTH USA facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2275132B1 03 Mar, 2021 Multivalent PCV2 immunogenic compositions and methods of producing them Dec, 2026 3
EP3127551B1 29 Jul, 2020 Pcv2 immunogenic composition for lessening clinical symptoms in pigs Dec, 2026 3
EP2460820B8 19 Jun, 2019 Pcv2 immunogenic compositions and methods of producing such compositions Dec, 2025 3
EP1968630B1 24 Jan, 2018 Multivalent pcv2 immunogenic compositions Dec, 2026 3
EP3035958B1 26 Oct, 2022 Porcine circovirus type 2 (pcv2) subunit vaccine Aug, 2034 2
EP3061454B1 10 Mar, 2021 Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof Jan, 2033 2
EP3320919B1 27 May, 2020 Multivalent pcv2 immunogenic compositions and methods of producing such compositions Dec, 2026 2
EP2481420B1 20 Feb, 2019 Single dose anti-PCV2 pig vaccine Dec, 2027 2
EP3554536B1 26 Oct, 2022 Recombinant hvt vectors expressing multiple antigens of avian pathogens, and vaccines comprising them Dec, 2037 1
EP2785374B2 17 Aug, 2022 Recombinant gallid herpesvirus 3 (mdv serotype 2) vectors expressing antigens of avian pathogens and uses thereof Nov, 2032 1
EP2998315B2 03 Nov, 2021 Newcastle disease virus vectored avian vaccines Apr, 2030 1
EP2874653B1 27 Dec, 2017 Method of providing protective immunity against heterologous leptospira strains Jul, 2033 1